BeStock  
Stocks › Biotechnology › VOR

Vor Biopharma VOR

US equityMarket cap rank #3164Biotechnology
$18.78 +$0.47 (+2.57%)
Pre-market · Oct 8, 7:00 am ET · After hours $18.78 0.00%
Open$18.09
Prev close$18.31
Day range$17.86 – $18.90
Volume563.1K
Market cap$1.11B
P/E (TTM)1.6
Dividend yield–

VOR Stock News

Headlines matching Vor Biopharma or the VOR ticker, most recent first.

  • Jefferies Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $48 NegativeMarket news · 9 Sep 2026 · Direct mention
  • Stifel Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $40Market news · 28 Sep 2026 · Direct mention
  • Citi Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $50Market news · 10 Sep 2026 · Direct mention
  • Wells Fargo Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $30Market news · 31 Aug 2026 · Direct mention
  • Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $27 PositiveMarket news · 12 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Vor Biopharma(VOR.US) With Buy Rating, Maintains Target Price $31Market news · 12 Aug 2026 · Direct mention
  • Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-10% Owner RA CAPITAL MANAGEMENT, L.P.SEC · 22 Jul 2026 · Direct mention
  • Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.SEC · 13 Jun 2026 · Direct mention
  • HC Wainwright & Co. Reiterates Buy on Vor Biopharma, Maintains $31 Price TargetBenzinga · 19 May 2026 · Direct mention
  • Vor Biopharma Price Target Maintained With a $31.00/Share by HC Wainwright & Co.Dow Jones · 19 May 2026 · Direct mention
  • TD Cowen Maintains Vor Biopharma(VOR.US) With Buy RatingMarket news · 14 May 2026 · Direct mention
  • Wedbush Maintains Vor Biopharma(VOR.US) With Hold Rating, Raises Target Price to $18 PositiveMarket news · 14 May 2026 · Direct mention
  • Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.SEC · 25 Apr 2026 · Direct mention
  • Vor Biopharma | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.SEC · 22 Apr 2026 · Direct mention
  • H.C. Wainwright Maintains Vor Biopharma(VOR.US) With Buy Rating, Cuts Target Price to $31 NegativeMarket news · 15 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on VOR.

Leave a comment

Scroll to Top